Physician profile
Jayesh Jag Patel
NPI 1427079169
$782.59
in general payments reported to CMS, 2019-2025
19 companies · $29.24 in 2025
The $29.24 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $503 · 2020: $85.23 · 2023: $77.51 · 2024: $87.85 · 2025: $29.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $194.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.33 | 2019-2020 | |
| Amarin Pharma, INC. | $74.68 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $73.17 | 2019 | |
| Janssen Pharmaceuticals, INC | $61.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $49.18 | 2020-2025 | Farxiga, Airsupra |
| E.R. Squibb & Sons, L.L.C. | $37.04 | 2019-2020 | |
| Pfizer INC. | $34.46 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $34.08 | 2019 | |
| Merck Sharp & Dohme LLC | $33.48 | 2019 | |
| Novo Nordisk INC | $33.44 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $32.62 | 2024 | |
| Sanofi-Aventis U.S. LLC | $31.86 | 2019 | |
| Lilly USA, LLC | $30.01 | 2019 | |
| Urgo Medical North America, LLC | $28.98 | 2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Genentech USA, INC. | $26.25 | 2024 | Ocrevus Zunovo, Ocrevus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $20.56 | 2023 | Hizentra |
| Ferring Pharmaceuticals INC. | $18.89 | 2023 | Euflexxa |
| Regeneron Healthcare Solutions, INC. | $15.72 | 2025 | Dupixent |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jayesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.